Healthcare | August 28, 2023
IBL Healthcare invests in KNISS Laboratories
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
This transformation will enable GE HealthCare to build a strong foundation for business growth
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
Intent to start at least 5 innovative Phase 3 vaccine programs by 2025
Subscribe To Our Newsletter & Stay Updated
